HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CLBT

Cellebrite DI Ltd. (NASDAQ)

Technology — Software - Infrastructure

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

None 7 analysts
$15.45
+$0.85 (+5.82%)
Target: $21.00 (35.9%)
Sign in to add CLBT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$3.85B
P/E Ratio (TTM)55.18
Forward P/E23.37
EPS (TTM)$0.28
Dividend Yield-
Profit Margin14.48%
Revenue Growth19.30%
ROE16.44%
Debt/Equity4.47
Recommendation None
Analyst Target$21.00
Analysts7
Indexes NASDAQ

Technical Indicators

RSI (14)74.8
Beta1.17
SMA 20-
SMA 40-
52-Week High$19.98
52-Week Low$11.02
50-Day Avg$13.33
200-Day Avg$15.60
Avg Volume$2.17M
Volume$3.23M

Performance Analysis

NEUTRAL

CLBT presents a mixed picture with both positive and negative indicators.

~ Trading at 49% of its 52-week range.
- RSI at 74.8 indicates overbought conditions — a pullback may be due.
- P/E of 55.2 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 19.3% year-over-year.
~ Wall Street consensus is "none" from 7 analysts.
+ Average analyst target of $21.00 implies 35.9% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:03 UTC

Back to Screener Export Report